8. Long – Term Debt, Continued:
9. Concentrations of Risk:
During the first three and nine months ended September 30, 2014 and 2013, the Chairman of the audit committee and compensation committee received $9,000 and $27,000, respectively, for services performed.
PART I - FINANCIAL INFORMATION, CONTINUED:
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited), Continued:
10. Related Party Transactions, Continued:
During the three and nine months ended September 30, 2014 and 2013, the Company paid $3,547 and $6,843 in 2014, respectively, and $14,793 and $52,739 in 2013, respectively, to John Lawrence, President and Chief financial Officer, as reimbursement for equipment used by th Company. Additionally during the quarter ended June 30, 2014, Mr. Lawrence loaned the Company $63,500 for operating expenses and was paid back $13,500 at June 30, 2014. The loan was non-inteest bearing and unsecured and the remainder was paid in full during July of 2014.
During the three and nine months ended September 30, 2014 and 2013, the Company paid royalty expenses, based on sales of zeolite, of $10,611 and $31,655, in 2014, respectively, and $11,885 and $34,494, in 2013, respectively, to a company controlled by the estate of Al Dugan, formerly a significant stockholder and the father of a former director.
11. Income Taxes:
The Company had recognized a deferred tax asset of $229,451 as of December 31, 2012. During the year ended December 31, 2013, the Company recognized a valuation allowance equal to 100% of the net deferred tax asset as management of the Company cannot determine that it is more likely than not the Company will realize the benefit of the net deferred tax asset. The net effect is that the deferred tax asset as of December 31, 2013, and any deferred tax assets that may have been incurred since then, are fully reserved for at September 30, 2014.
12. Stockholder’s Equity:
Issuance of Common Stock for Cash
During the nine months ended September 30, 2014, the Company sold an aggregate of 2,217,571 shares of its common stock pursuant to a Form S-3 registration statement for $1.40 per share. The sales resulted in $2,831,134 of net proceeds to the Company.
Issuance of Common Stock for Notes Payable
In the fourth quarter of 2013, the Company borrowed $150,000 from Mr. and Mrs. Robert Detwiler, stockholders of the Company. Prior to the end of 2013, the Detwiler’s converted their notes into 120,000 shares common stock and 60,000 stock purchase warrants. The terms of the conversion were identical to those offered other investors that purchased common stock and warrants near the time of the conversion and no gain or loss on the conversion resulted. During the three months ended June 30, 2014, the Company issued 235,717 shares of its commons stock to Mr. and Mrs. Robert Detwiler and two other shareholders in satisfaction of $330,000 of additional debt that the Detwilers and two other shareholders had loaned the Company. Again, the terms of the share payment were identical to those offered other investors that purchased common stock during the second quarter offering.
PART I - FINANCIAL INFORMATION, CONTINUED:
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited), Continued:
12. Stockholder’s Equity, Continued:
Warrant Exercise
During the quarter ended June 30, 2014, the Company issued an aggregate of 310,625 shares of its common stock to existing shareholders of the Company for their exercise of common stock purchase warrants. Of the shares issued, 182,500 generated cash proceeds of $239,000; 3,125 shares were issued in connection with a cashless exercise of warrants; and 125,000 shares were issued in connection with the receipt of notes receivable promising to pay $150,000 to the Company.
Issuance of Common Stock for Services
Directors
On December 27, 2013, the Company declared, but did not issue, shares of unregistered common stock to be paid to its directors for services during 2013, having a fair value of $150,000, based on the current stock price at the date declared. During the nine months ended September 30, 2014, the Company issued 83,334 shares in satisfaction of the obligation.
Consultants
During the nine months ended September 30, 2014, the Company issued 24,000 shares to Herbert Denton for investor relations services provided. The shares estimated fair value at the time of issue was approximately $39,000.
Common Stock Warrants
The Company's Board of Directors has the authority to issue stock warrants for the purchase of preferred or unregistered common stock to directors and employees of the Company.
Transactions in common stock warrants are as follows:
| | Number of Warrants | | | Exercise Prices | |
Balance, December 31, 2011 | | | 600,000 | | | $ | .30 - $.60 | |
Warrants issued | | | 1,734,667 | | | $ | 2.50 - $4.50 | |
Warrants exercised | | | (250,000 | ) | | $ | .30 - $2.50 | |
Warrants expired | | | (150,000 | ) | | $ | .30 - $.40 | |
Balance, December 31, 2012 | | | 1,934,667 | | | $ | .25 - $4.50 | |
Warrants issued | | | 629,740 | | | $ | 1.20-$1.60 | |
Warrants exercised | | | (25,000 | ) | | $ | 1.20 | |
Warrants expired | | | (50,000 | ) | | $ | 4.50 | |
Balance, December 31, 2013 | | | 2,489,407 | | | $ | 0.25 - $4.50 | |
Warrants exercised | | | (320,000 | ) | | $ | 1.20-$1.60 | |
Warrants expired | | | (1,337,750 | ) | | | | |
Balance, September 30, 2014 | | | 831,657 | | | $ | 0.25 - $4.50 | |
| | | | | | | | |
The above common stock warrants expire as follows: | | | | | |
Year ended December 31: | | | | | | | | |
2014 | | | 179,740 | | | | | |
2015 | | | 401,917 | | | | | |
Thereafter | | | 250,000 | | | | | |
| | | 831,657 | | | | | |
PART I - FINANCIAL INFORMATION, CONTINUED:
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited), Continued:
13. Business Segments:
The Company is currently organized and managed by three segments, which represent our operating units: United States antimony operations, Mexican antimony operations and United States zeolite operations. The Company’s Other operating costs include general and administrative expenses, freight and delivery, and other non-production related costs. Other income and expense consists primarily of interest income and expense and factoring expense.
The Madero smelter and Puerto Blanco mill at the Company’s Mexico operation brings antimony to an intermediate stage, which is then shipped to the United States operation for finishing and sales at the Thompson Falls, Montana plant. The Zeolite operation produces Zeolite near Preston, Idaho. Almost all of the sales of products from the United States antimony and Zeolite operations are to customers in the United States.
Segment disclosure regarding sales to major customers is located in Notes 9.
| | As of September 30, 2014 | | | As of December 31, 2013 | |
Properties, plants and equipment, net: | | | | | | |
Antimony | | | | | | |
United States | | $ | 1,951,393 | | | $ | 1,928,442 | |
Mexico | | | 9,653,683 | | | | 8,792,410 | |
Subtotal Antimony | | | 11,605,076 | | | | 10,720,852 | |
Zeolite | | | 1,593,089 | | | | 1,674,793 | |
| | $ | 13,198,165 | | | $ | 12,395,645 | |
| | | | | | | | |
Total Assets: | | | | | | | | |
Antimony | | | | | | | | |
United States | | $ | 3,885,788 | | | $ | 3,017,768 | |
Mexico | | | 10,870,955 | | | | 9,668,997 | |
Subtotal Antimony | | | 14,756,743 | | | | 12,686,765 | |
Zeolite | | | 2,047,138 | | | | 2,204,226 | |
| | $ | 16,803,881 | | | $ | 14,890,991 | |
| | For the three months ended | | | For the nine months ended | |
| | September 30, 2014 | | | September 30, 2013 | | | September 30, 2014 | | | September 30, 2013 | |
Capital expenditures: | | | | | | | | | | | | |
Antimony | | | | | | | | | | | | |
United States | | $ | 3,166 | | | $ | 4,883 | | | $ | 77,059 | | | $ | 79,630 | |
Mexico | | | 647,222 | | | | 411,089 | | | | 1,174,225 | | | | 1,834,194 | |
Subtotal Antimony | | | 650,388 | | | | 415,972 | | | | 1,251,284 | | | | 1,913,824 | |
Zeolite | | | 33,180 | | | | 50,551 | | | | 83,602 | | | | 156,563 | |
Total | | $ | 683,568 | | | $ | 466,523 | | | $ | 1,334,886 | | | $ | 2,070,387 | |
PART I - FINANCIAL INFORMATION, CONTINUED:
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited), Continued:
13. Business Segments, Continued: